Prevention and Immunization, the Key to Achieve a More
Experts in vaccination from Germany, France and Spain, invited by the Bamberg Foundation, met in Berlin to discuss the key strategic priorities that will...
Stay updated with breaking news from Beate Kampmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts in vaccination from Germany, France and Spain, invited by the Bamberg Foundation, met in Berlin to discuss the key strategic priorities that will...
Vaccinating women in pregnancy can protect women and their infants from infectious diseases. This intervention is increasingly recognised as a safe and effective way to reduce infant morbidity and mortality.
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study has now investigated the efficacy of an initial vaccine candidate.
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study involving Charité –
Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants.